Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Acute-on-chronic liver failure (ACLF) is a catastrophic illness. Few studies investigated the prognostic value of vitamin D-binding protein (VDBP) for hepatitis B virus (HBV)-related ACLF (HBV-ACLF) resulted in conflicting results. Methods: Two prospective HBV-ACLF cohorts (n=287 and n=119) were enrolled to assess and validate the prognostic performance of VDBP. Results: VDBP levels in the non-survivors were significantly lower than in the survivors (P<0.001). Multivariate Cox regression demonstrated that VDBP was an independent prognostic factor for HBV-ACLF. The VDBP level at admission gradually decreased as the number of failed organs increased (P<0.001), and it was closely related to coagulation failure. The areas under the receiver operating characteristic curve (AUCs) of the Child-Pugh-VDBP and chronic liver failuresequential organ failure assessment (CLIF–SOFA)-VDBP scores were significantly higher than those of Child-Pugh (P<0.001) and CLIF-SOFA (P=0.0013). The AUCs of model for end-stage liver disease (MELD)-VDBP were significantly higher than those of MELD (P= 0.0384) only in the case of cirrhotic HBV-ACLF patients. Similar results were validated using an external multicenter HBV-ACLF cohort. By longitudinal observation, the VDBP levels gradually increased in survivors (P=0.026) and gradually decreased in non-survivors (P<0.001). Additionally, the VDBP levels were found to be significantly decreased in the deterioration group (P=0.012) and tended to be decreased in the fluctuation group (P=0.055). In contrast, they showed a significant increase in the improvement group (P=0.036). Conclusions: The VDBP was a promising prognostic biomarker for HBV-ACLF. Sequential measurement of circulating VDBP shows value for the monitoring of ACLF progression.
Abstract
Background/Aims: Acute-on-chronic liver failure (ACLF) is a catastrophic illness. Few studies investigated the prognostic value of vitamin D-binding protein (VDBP) for hepatitis B virus (HBV)-related ACLF (HBV-ACLF) resulted in conflicting results. Methods: Two prospective HBV-ACLF cohorts (n=287 and n=119) were enrolled to assess and validate the prognostic performance of VDBP. Results: VDBP levels in the non-survivors were significantly lower than in the survivors (P<0.001). Multivariate Cox regression demonstrated that VDBP was an independent prognostic factor for HBV-ACLF. The VDBP level at admission gradually decreased as the number of failed organs increased (P<0.001), and it was closely related to coagulation failure. The areas under the receiver operating characteristic curve (AUCs) of the Child-Pugh-VDBP and chronic liver failuresequential organ failure assessment (CLIF–SOFA)-VDBP scores were significantly higher than those of Child-Pugh (P<0.001) and CLIF-SOFA (P=0.0013). The AUCs of model for end-stage liver disease (MELD)-VDBP were significantly higher than those of MELD (P= 0.0384) only in the case of cirrhotic HBV-ACLF patients. Similar results were validated using an external multicenter HBV-ACLF cohort. By longitudinal observation, the VDBP levels gradually increased in survivors (P=0.026) and gradually decreased in non-survivors (P<0.001). Additionally, the VDBP levels were found to be significantly decreased in the deterioration group (P=0.012) and tended to be decreased in the fluctuation group (P=0.055). In contrast, they showed a significant increase in the improvement group (P=0.036). Conclusions: The VDBP was a promising prognostic biomarker for HBV-ACLF. Sequential measurement of circulating VDBP shows value for the monitoring of ACLF progression.
참고문헌 (28)
- Arroyo V, "Acute-on-chronic liver failure", N Engl J Med, 382, pp.2137~2145 (2020)
- Moreau R, "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis", Gastroenterology, 144, pp.1426~1437 (2013)[DOI]
- Wu T, "Development of diagnostic criteria and a prognostic score for hepatitis B virusrelated acute-on-chronic liver failure", Gut, 67, pp.2181~2191 (2018)
- Arroyo V, "Acute-on-chronic liver failure in cirrhosis", Nat Rev Dis Primers, 2, pp.16041~ (2016)
- Sarin SK, "Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL) : an update", Hepatol Int, 13, pp.353~390 (2019)
- Berry PA, "Review article : towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis", Aliment Pharmacol Ther (2013)
- Shawcross DL, "The impact of organ dysfunction in cirrhosis : survival at a cost?", J Hepatol, 56, pp.1054~1062 (2012)
- Schmidt ML, "Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010", Gastroenterology, 148, pp.967~977 (2015)
- Wu D, "Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure", J Clin Invest, 130, pp.2069~2080 (2020)
- Sun Z, "Circulating proteomic panels for diagnosis and risk stratification of acute-onchronic liver failure in patients with viral hepatitis B", Theranostics, 9, pp.1200~1214 (2019)
- Dragoi D, "Proteomics analysis of monocyte-derived hepatocyte-like cells identifies integrin beta 3 as a specific biomarker for druginduced liver injury by diclofenac", Front Pharmacol, 9, pp.699~ (2018)
- Zhou N, "Discovery of a potential plasma protein biomarker panel for acute-onchronic liver failure induced by hepatitis B virus", Front Physiol, 8, pp.1009~ (2017)
- Schiødt FV, "Admission levels of serum Gc-globulin : predictive value in fulminant hepatic failure", Hepatology, 23, pp.713~718 (1996)
- Goldschmidt-Clermont PJ, "Proportion of circulating Gc(vitamin D-binding protein)in complexed form : relation to clinical outcome in fulminant hepatic necrosis", Gastroenterology, 94, pp.1454~1458 (1988)
- Schiødt FV, "Gc-globulin and prognosis in acute liver failure", Liver Transpl, 11, pp.1223~1227 (2005)
- Grama A, "Vitamin D-binding protein(Gc-globulin)in acute liver failure in children", Diagnostics(Basel), 10, pp.278~ (2020)
- Yin Z, "Prognostic value of Gc-globulin in Chinese patients with acute-on-chronic hepatitis B liver failure", J Coll Physicians Surg Pak, 25, pp.176~180 (2015)
- Liu H, "Plasma actin-free Gcglobulin in patients with chronic or acute-on-chronic liver failure caused by hepatitis B virus", Gastroenterology Res, 2, pp.213~219 (2009)
- Wu D, "HINT : a novel prognostic model for patients with hepatitis B virusrelated acute-on-chronic liver failure", Aliment Pharmacol Ther, 48, pp.750~760 (2018)
- Haddad JG, "Angiopathic consequences of saturating the plasma scavenger system for actin", Proc Natl Acad Sci U S A, 87, pp.1381~1385 (1990)
- Schiødt FV, "Reduced serum Gcglobulin concentrations in patients with fulminant hepatic failure : association with multiple organ failure", Crit Care Med, 25, pp.1366~1370 (1997)
- Lee WM, "Predicting survival in fulminant hepatic failure using serum Gc protein concentrations", Hepatology, 21, pp.101~105 (1995)
- Schiødt FV, "Predictive value of actin-free Gc-globulin in acute liver failure", Liver Transpl, 13, pp.1324~1329 (2007)
- Schiødt FV, "Increased turnover of Gc-globulin in patients with hepatic encephalopathy", Scand J Gastroenterol, 36, pp.998~1003 (2001)
- Wang X, "Definition of ACLF and inclusion criteria for extra-hepatic organ failure", Hepatol Int, 9, pp.360~365 (2015)
- Lu CY, "Dynamic prognostication in transplant candidates with acute-on-chronic liver failure", J Pers Med, 10, pp.230~ (2020)
- Marshall JC. Inflammation, "and the pathogenesis of multiple organ dysfunction syndrome", Crit Care Med (2001)
- Bikle DD, "Vitamin D binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions", Front Endocrinol(Lausanne), 10, pp.317~ (2019)